Mesenchymal stem cell conditioned medium ameliorates diabetic serum-induced insulin resistance in 3T3-L1 cells
Background: Pharmacological factors used to induce insulin resistance (IR) in in vitro models may not mimic the full in vivo features of type 2 diabetes mellitus (T2DM). This study aimed to examine the ability of diabetic serum (DS) to induce IR and investigate whether adipose-derived mesenchymal st...
Guardado en:
Autores principales: | Avinash Sanap, Ramesh Bhonde, Kalpana Joshi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a006f290cd43478e947fc74928b186ad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mesenchymal stem cells as a platform for research on traditional medicine
por: Ramesh Bhonde, et al.
Publicado: (2021) -
Melatonin Promotes the Therapeutic Effect of Mesenchymal Stem Cells on Type 2 Diabetes Mellitus by Regulating TGF-β Pathway
por: Balun Li, et al.
Publicado: (2021) -
Emerging Antioxidant Paradigm of Mesenchymal Stem Cell-Derived Exosome Therapy
por: Chen Xia, et al.
Publicado: (2021) -
Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration
por: Hongbing Lin, et al.
Publicado: (2021) -
Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review
por: Figueroa,Fernando E, et al.
Publicado: (2012)